Corporate Overview

Electromed develops, manufactures, markets and sells innovative airway clearance products, including SmartVest® Airway Clearance System, for use primarily in the home setting.

We employ a direct-to-patient and provider model, through which we obtain patient referrals from clinicians, manage insurance claims on behalf of our patients and their clinicians, deliver our solutions to patients and train them on proper use in their homes.

We strive to improve quality of life for patients with compromised pulmonary function, reduce healthcare utilization and, in turn, enhance value for our shareholders by providing airway clearance products designed for patient comfort and ease of use.

An older SmartVest patient performs his HFCWO therapy as he's completing a crossword puzzle.

Events:

November 14, 2018 - 9:00 am ET

September 26, 2018 - 9:00 am ET

An older SmartVest patient performs his HFCWO therapy as he's completing a crossword puzzle.
An older SmartVest patient performs his HFCWO therapy as he's completing a crossword puzzle.

NYSE American | ELMD

  • Price: $ 5.32
  • Change: $(0.34) (6.01)%
  • Market Cap ($ M): 47.28
  • "As of December 14, 2018 2:10 PM ET" (Price delay 20 minutes)